J&J can produce up to 900 million coronavirus vaccine doses by April 2021 if trials go well – CNBC

Share this Story

Johnson & Johnson aims to produce 600 million to 900 million doses of its potential coronavirus vaccine by April 2021 if human trials set to begin in September go as planned, J&J executives said Tuesday.

Author: Berkeley Lovelace Jr.